AlphAIAlphAI — Financial news for AI agents
theglobeandmail.comSEP 162 min read$BRO

BRO Stock Declines 27.1% in a Year: What Should Investors Do Now?

Brown & Brown (BRO) shares fell 27.1% in the past year, underperforming the industry. Factors include soft organic growth, elevated costs, and acquisition debt. Analysts see a 12.2% upside to $76.69. The company projects 2026 EPS growth of 5.6% and revenue growth of 19.2%. Competitors AON, AJG, and WTW also declined. BRO trades at a discount with a forward P/E of 14.12x.

Original reporting
theglobeandmail.com
Published Sep 16, 2026, 4:52 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 16, 2026, 8:39 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
BRO Stock Declines 27.1% in a Year: What Should Investors Do Now? — source image
Source · theglobeandmail.com
Decision brief

The 30-second read

$BRONeutralLow
01

Why it matters

The piece is a recap of existing metrics and analyst estimates, offering limited actionable insight.

02

Market read

Provides a snapshot of BRO's current valuation and growth outlook; minimal impact on broader market.

03

What to watch

Potential upside from AI-driven efficiency gains and upcoming acquisition synergies not fully priced in.

Relevance 4/10Novelty 2/10Timing: none

Background

Brown & Brown (BRO) has underperformed its peers over the past year; Zacks provides valuation and target price analysis.

Company-level read

Ticker impact

$BRONeutralMedium confidence
Context

Article reviews BRO's 27.1% price decline, valuation discount, Zacks target and growth estimates, but provides no new corporate event.

Expected impact

Limited upside, likely range-bound unless new catalyst emerges.

Evidence & confidence

Analysis is based on existing data; no fresh news to drive price movement.

Market effects

Sector

Highlights broader pressure on insurance brokers; valuation discounts may affect peers.

Regional

U.S. insurance brokerage sector sees mixed performance; no immediate regional shift.

Global

Limited; article focuses on a single U.S. broker.

Counterpoint

What could challenge this read

Despite valuation discount, BRO's strong cash flow and AI investments could drive a rebound if debt is managed.

Key entities

  • Company
    Brown & Brown, Inc.

    U.S.-listed insurance broker (ticker BRO).

Read at source← All news

Related articles

OCT 7
$BROMed

Brown & Brown gets bullish rating as Oppenheimer starts coverage of P&C brokers (BRO:NYSE)

Oppenheimer initiated coverage of property & casualty insurance brokers, rating Brown & Brown (BRO) Outperform and Arthur J. Gallagher (AJG) Sector Perform. The firm expects BRO's organic growth to improve, driven by the Accession acquisition, while noting durable growth prospects for brokerages. However, AJG's margin improvement is expected to stall due to integration and industry challenges.

seekingalpha.com1 min
SEP 16
$BROMedAI 8/10

Winners And Losers Of Q2: Baldwin Insurance Group (NASDAQ:BWIN) Vs The Rest Of The Insurance Brokers Stocks

Ryan Specialty beat estimates but fell 11.1% to $39.20. Brown & Brown (BRO) reported $1.68B revenue, up 30.4% YoY, missing estimates by 2.5%, and dropped 3.4% to $67.32. Arthur J. Gallagher (AJG) reported $4.00B revenue, up 24.3% YoY, missing estimates by 0.5%, and fell 3.3% to $248.05. Marsh (MRSH) reported $7.40B revenue, up 6.2% YoY, beating estimates by 1.8%, and dropped 1.2% to $179.91.

finance.yahoo.com2 min
JUL 28
$BROMed

Why Are Brown & Brown (BRO) Shares Soaring Today

Brown & Brown (NYSE: BRO) shares rose about 5% after the company reported Q2 results. Revenue increased 30.4% year over year to $1.68B, slightly below analysts’ $1.72B estimate. Adjusted EPS was $1.07, in line with expectations, driving investor focus on strong growth despite the revenue miss.

financialcontent.com4 min
JUL 28
$BROMed

Brown & Brown Q2 Earnings Call Highlights

Brown & Brown (NYSE:BRO) discussed Q2 results on its earnings call. CFO Andy Watts said Retail revenue rose 35.9% mainly from acquisitions, while Retail organic growth was pressured by a pharmacy consulting business and a litigation-related organic revenue adjustment. Specialty Distribution total revenue rose 28.1% on Accession, with EBITDAC margin down to 42.7%. BRO expects H2 Retail organic growth excluding contingents of 1.5% to 2.5% and Specialty 2% to 4%, and reaffirmed $30M-$40M integratio

yahoo.com7 min